Stanley-Laman Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Sell |
51,003
-7,846
| -13% | -$548K | 0.53% | 83 |
|
|
2025
Q1 | $4.33M | Buy |
58,849
+9,614
| +20% | +$707K | 0.67% | 51 |
|
|
2024
Q4 | $3.23M | Sell |
49,235
-15,256
| -24% | -$1,000K | 0.45% | 98 |
|
|
2024
Q3 | $5.02M | Buy |
64,491
+2,162
| +3% | +$168K | 0.71% | 42 |
|
|
2024
Q2 | $4.86M | Buy |
62,329
+2,675
| +4% | +$209K | 0.7% | 43 |
|
|
2024
Q1 | $4.04M | Buy |
59,654
+425
| +0.7% | +$28.8K | 0.57% | 76 |
|
|
2023
Q4 | $3.99M | Buy |
59,229
+6,277
| +12% | +$423K | 0.61% | 53 |
|
|
2023
Q3 | $3.59M | Buy |
+52,952
| New | +$3.59M | 0.61% | 61 |
|
|
2017
Q2 | – | Sell |
-77,282
| Closed | -$2.41M | – | 201 |
|
|
2017
Q1 | $2.41M | Buy |
77,282
+24,394
| +46% | +$760K | 0.65% | 49 |
|
|
2016
Q4 | $1.45M | Buy |
52,888
+5,941
| +13% | +$162K | 0.45% | 77 |
|
|
2016
Q3 | $1.54M | Sell |
46,947
-406
| -0.9% | -$13.3K | 0.63% | 33 |
|
|
2016
Q2 | $1.43M | Buy |
47,353
+18,835
| +66% | +$569K | 0.56% | 43 |
|
|
2016
Q1 | $803K | Sell |
28,518
-56,857
| -67% | -$1.6M | 0.15% | 138 |
|
|
2015
Q4 | $2.9M | Sell |
85,375
-41,363
| -33% | -$1.4M | 0.5% | 64 |
|
|
2015
Q3 | $4.03M | Sell |
126,738
-9,490
| -7% | -$302K | 0.82% | 36 |
|
|
2015
Q2 | $4.34M | Buy |
136,228
+86
| +0.1% | +$2.74K | 0.8% | 38 |
|
|
2015
Q1 | $4.66M | Sell |
136,142
-1,930
| -1% | -$66K | 0.85% | 39 |
|
|
2014
Q4 | $4.86M | Sell |
138,072
-7,956
| -5% | -$280K | 0.92% | 32 |
|
|
2014
Q3 | $5.22M | Sell |
146,028
-682
| -0.5% | -$24.4K | 1.01% | 28 |
|
|
2014
Q2 | $5.45M | Buy |
146,710
+576
| +0.4% | +$21.4K | 1% | 29 |
|
|
2014
Q1 | $4.74M | Buy |
146,134
+2,364
| +2% | +$76.7K | 0.83% | 39 |
|
|
2013
Q4 | $4.27M | Buy |
+143,770
| New | +$4.27M | 0.93% | 35 |
|